A G Singal1, L V Thomassen, D R Gretch, M C Shuhart. 1. Department of Medicine, University of Texas Southwestern Medical Center, Dallas, 75390-8887, USA. amit.singal@utsouthwestern.edu
Abstract
BACKGROUND: The AST to platelet ratio index (APRI), a non-invasive marker of liver fibrosis, has not been well studied in HCV/HIV (hepatitis C virus/human immunodeficiency virus) co-infected patients with advanced HIV. AIM: To compare the accuracy of APRI in HCV/HIV co-infected patients to that in HCV mono-infected patients and to determine the impact of CD4+ T-cell counts on its performance. METHODS: We identified 106 consecutive HCV/HIV co-infected patients and 105 matched HCV mono-infected patients who underwent liver biopsy at Harborview Medical Center over a 5-year period. Performance characteristics were calculated and receiver operating characteristic (ROC) analysis conducted. RESULTS: The area under the ROC curve (AUROC) of APRI for predicting significant fibrosis was similar when comparing those with and without HIV co-infection (0.77 vs. 0.86, P = 0.18), but was lower in HIV co-infected patients with CD4 counts <250 cells/mm³ (0.64 vs. 0.86, P = 0.05). In HIV co-infected patients with CD4 counts ≥250, APRI had higher negative predictive value (93% vs. 88%, P = 0.57), positive predictive value (63% vs. 40%, P = 0.43) and specificity (95% vs. 88%, P = 0.05) than in those with lower CD4 counts. CONCLUSIONS: The AST to platelet ratio index (APRI) performance characteristics appear to be suboptimal in HCV/HIV co-infected patients with CD4 counts <250 and they require further study in this population at increased risk for advanced liver disease.
BACKGROUND: The AST to platelet ratio index (APRI), a non-invasive marker of liver fibrosis, has not been well studied in HCV/HIV (hepatitis C virus/human immunodeficiency virus) co-infectedpatients with advanced HIV. AIM: To compare the accuracy of APRI in HCV/HIV co-infectedpatients to that in HCV mono-infected patients and to determine the impact of CD4+ T-cell counts on its performance. METHODS: We identified 106 consecutive HCV/HIV co-infectedpatients and 105 matched HCV mono-infected patients who underwent liver biopsy at Harborview Medical Center over a 5-year period. Performance characteristics were calculated and receiver operating characteristic (ROC) analysis conducted. RESULTS: The area under the ROC curve (AUROC) of APRI for predicting significant fibrosis was similar when comparing those with and without HIV co-infection (0.77 vs. 0.86, P = 0.18), but was lower in HIV co-infectedpatients with CD4 counts <250 cells/mm³ (0.64 vs. 0.86, P = 0.05). In HIV co-infectedpatients with CD4 counts ≥250, APRI had higher negative predictive value (93% vs. 88%, P = 0.57), positive predictive value (63% vs. 40%, P = 0.43) and specificity (95% vs. 88%, P = 0.05) than in those with lower CD4 counts. CONCLUSIONS: The AST to platelet ratio index (APRI) performance characteristics appear to be suboptimal in HCV/HIV co-infectedpatients with CD4 counts <250 and they require further study in this population at increased risk for advanced liver disease.
Authors: Xavier Forns; Sergi Ampurdanès; Josep M Llovet; John Aponte; Llorenç Quintó; Eva Martínez-Bauer; Miquel Bruguera; Jose Maria Sánchez-Tapias; Juan Rodés Journal: Hepatology Date: 2002-10 Impact factor: 17.425
Authors: M Puoti; M Bonacini; A Spinetti; V Putzolu; S Govindarajan; S Zaltron; M Favret; F Callea; F Gargiulo; F Donato; G Carosi Journal: J Infect Dis Date: 2000-11-16 Impact factor: 5.226
Authors: Robert P Myers; Yves Benhamou; Françoise Imbert-Bismut; Vincent Thibault; Marie Bochet; Frédéric Charlotte; Vlad Ratziu; François Bricaire; Christine Katlama; Thierry Poynard Journal: AIDS Date: 2003-03-28 Impact factor: 4.177
Authors: A H Mohsen; P J Easterbrook; C Taylor; B Portmann; R Kulasegaram; S Murad; M Wiselka; S Norris Journal: Gut Date: 2003-07 Impact factor: 23.059
Authors: Purva Gopal; Adam C Yopp; Akbar K Waljee; Jason Chiang; Mahendra Nehra; Pragathi Kandunoori; Amit G Singal Journal: Clin Gastroenterol Hepatol Date: 2013-10-02 Impact factor: 11.382
Authors: Seble Kassaye; Ying Li; Gregory Huhn; Marion G Peters; Audrey L French; Phyllis C Tien; Bruce Luxon; Michael W Plankey Journal: J AIDS Clin Res Date: 2015-04